Search
for

    Sort by

    Research 91–120 of 1000+

    1. Clinical benefits and adverse effects of genetically-elevated free testosterone levels: a Mendelian randomization analysis 2019 · 4 citations
    2. Current Literature Review The Journal of Sexual Medicine · 2013
    3. Does a male polycystic ovarian syndrome equivalent exist? Journal of Endocrinological Investigation · 2017 · 28 citations
    4. Patterns of Care for Newly Diagnosed Benign Prostatic Hyperplasia in the United States 2016 · 4 citations
    5. News in brief Expert Review of Endocrinology & Metabolism · 2011
    6. Androstenedione Strength and Conditioning Journal · 1999
    7. MP44-04 TRENDS IN 5-ALPHA REDUCTASE INHIBITOR USE BEFORE AND AFTER THE FOOD AND DRUG ADMINISTRATION SAFETY WARNING 2019
    8. Comorbidities in patients with androgenetic alopecia: cardiovascular risk factors and benign prostatic hyperplasia 2011
    9. Zhuangyao Jianshen pill ameliorates testosterone-induced benign postatic hyperplasia in rats. PubMed · 2024 · 1 citations
    10. Finasteride: Middle-Age Cure-All for Alopecia and Benign Prostatic Hyperplasia? Mayo Clinic Proceedings · 2006
    11. Highlights of This Issue Cancer Epidemiology Biomarkers & Prevention · 2011
    12. Chapter 17. Selective androgen receptor modulators (SARMs) Annual Reports in Medicinal Chemistry · 2001 · 18 citations
    13. Cancer risk by the subtype of alopecia Scientific Reports · 2018 · 9 citations
    14. Factors Driving Unique Urination Phenotypes of Male and Female 9-week-old C57BL/6J Mice bioRxiv (Cold Spring Harbor Laboratory) · 2019
    15. Review Article: Practical Aspects of Testosterone Deficiency Syndrome in Clinical Urology African Journal of Urology · 2012
    16. CAN PATIENTS WITH LUTS AND BPH DISCERN CHANGES IN PEAK URINARY FLOW RATE AND DO SUCH CHANGES CONTRIBUTE TO OVERALL SATISFACTION WITH TREATMENT? The Journal of Urology · 2009
    17. Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia Frontiers in Pharmacology · 2020 · 35 citations
    18. Efficacy and safety of Finasteride (5 alpha-reductase inhibitor) monotherapy in patients with benign prostatic hyperplasia: A critical review of the literature Archivio Italiano di Urologia e Andrologia · 2020 · 14 citations
    19. Ferret adrenal-associated endocrinopathy. PubMed · 1998 · 9 citations
    20. Combination of finasteride and tamsulosine in the treatment of male lower urinary tract symptoms: What patients are thinking about? European Urology Supplements · 2018
    21. Development of a new gas chromatography–mass spectrometry (GC–MS) methodology for the evaluation of 5α-reductase activity Talanta · 2013 · 17 citations
    22. titanflow 2026
    23. Efeitos de diferentes doses do Minoxidil oral, em dois tempos de exposição, no complexo prostático de camundongos Balb/C 2024
    24. MP73-14 TRANSURETHRAL RESECTION URINARY RETENTION PREDICTOR (TURP) SCORE: A NOVEL PERIOPERATIVE PREDICTOR OF POST-OPERATIVE URINARY RETENTION 2018
    25. The Over‐The‐Counter Finasteride Alternative: A Critical Review of Saw Palmetto's Efficacy, Safety, and Regulatory Concerns International Journal of Dermatology · 2025
    26. Medicine Update IJCP · 2024
    27. Adverse Effects of 5-Alpha-Reductase Inhibitors: a narrative review Revista Eletrônica Acervo Médico · 2022
    28. Determination of the potency of a novel saw palmetto supercritical CO2 extract (SPSE) for 5α-reductase isoform II inhibition using a cell-free in vitro test system Research and reports in urology · 2016 · 3 citations
    29. Determination of the potency of a novel saw palmetto supercritical CO2 extract (SPSE) for 5α-reductase isoform II inhibition using a cell-free in vitro test system DOAJ (DOAJ: Directory of Open Access Journals) · 2016 · 2 citations
    30. Uromedic® Pumpkin Seed Derived Δ7-Sterols, Extract and Oil Inhibit 5α-Reductases and Bind to Androgen Receptor <em>in Vitro</em> Pharmacology & pharmacy · 2018 · 12 citations